查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632613

全球臨床實驗支援服務市場：市場規模、佔有率和趨勢分析（按階段、服務、贊助商、地區和細分市場，2025-2030 年）

Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phases (Phase I, Phase II, Phase III, Phase IV), By Service, By Sponsor, By Region (North America, Europe, APAC), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

臨床實驗支持服務市場的成長與趨勢：

預計到 2030 年全球臨床實驗支援服務市場規模將達到 371.6 億美元，2025 年至 2030 年期間的複合年成長率為 7.72%。

提供臨床實驗支援服務的CRO數量的增加以及製藥和生物製藥公司對研發的巨額投資是市場成長的主要因素。該行業受到了 COVID-19 疫情的影響。 2020年的疫情嚴重擾亂了供應鏈。然而，成長路徑也已顯現，包括透過併購和在臨床研究中採用數位技術。

一些令人擔憂的臨床實驗試驗統計數據包括 85% 的試驗沒有招募到足夠的參與者，80% 的試驗因招募困難而被推遲，以及參與者的退出率不斷上升。但要克服這一點，您需要一個有吸引力且明確的患者保留策略。知情同意資料易於理解非常重要。 CISCRP 的一項調查發現，35% 的後來退出的研究參與者表示他們發現知情同意書難以理解。由於美國的平均學術能力約為七年級或八年級，因此在將材料提交給機構審查委員會 (IRB) 之前對其進行分析非常重要。

臨床實驗支援服務業採用虛擬臨床實驗是推動疫情後收益成長的關鍵因素之一。越來越多的臨床研究組織正在轉向虛擬技術來簡化臨床研究服務。根據 Veeva 統一臨床營運調查的最新年度 CRO 報告，CRO 正在大力加快和實現臨床實驗的現代化。根據 Veeva Systems 的調查結果，CRO 正在採取果斷行動，採用新技術和數位策略來取代手動任務、打破資訊孤島並實現臨床實驗協作，以簡化臨床實驗試驗的執行。

臨床實驗支援服務市場報告重點

  • 2024 年臨床實驗現場管理佔最大的市場佔有率，為 45.73%。與監控和確保臨床實驗臨床實驗相關的高成本是佔最大佔有率的主要因素之一。
  • 第三階段部分佔據市場主導地位，佔54.43%的銷售佔有率。第三階段臨床臨床實驗的費用昂貴，因為涉及大量受試者。由於樣本量和研究設計需要在最佳水平上進行複雜的劑量控制，因此此階段的失敗率最高。
  • 2024 年，製藥和生物製藥公司部門佔據市場主導地位，收益佔有率最大，為 70.80%。不斷增加的研發投入和新藥的推出是推動該領域市場發展的主要動力。
  • 2024 年，北美佔據全球市場主導地位，佔有 48.80% 的最大佔有率。這是因為許多美國製藥公司的大部分業務都在該地區開展。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章臨床實驗支援服務市場：因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 臨床實驗支援服務市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
    • COVID-19影響分析
    • 重大資本交易及策略聯盟分析

第 4 章臨床實驗支援服務市場：各階段的估計與趨勢分析

  • 臨床實驗支援服務市場：細分儀表板（按階段）
  • 臨床實驗支援服務市場：按階段進行趨勢分析
  • 階段（2018-2030）
  • 第一階段
    • 第一階段市場（2018-2030年）
    • 臨床實驗現場管理
    • 病患招募管理
    • 資料管理
    • 管理人員
    • IRBS
    • 其他
  • 第二階段
    • 第二階段市場（2018-2030年）
    • 臨床實驗現場管理
    • 病患招募管理
    • 資料管理
    • 管理人員
    • IRBS
    • 其他
  • 第三階段
    • 第三階段市場（2018-2030年）
    • 臨床實驗現場管理
    • 病患招募管理
    • 資料管理
    • 管理人員
    • IRBS
    • 其他
  • 第四階段
    • 第四階段市場（2018-2030年）
    • 臨床實驗現場管理
    • 病患招募管理
    • 資料管理
    • 管理人員
    • IRBS
    • 其他

第 5 章臨床實驗支援服務市場：按服務分類的估計和趨勢分析

  • 臨床實驗支援服務市場：細分儀表板（按服務）
  • 臨床實驗支援服務市場：按服務進行波動分析
  • 依服務分類（2018-2030 年）
  • 臨床實驗現場管理
    • 臨床實驗現場管理市場（2018-2030）
  • 病患招募管理
    • 病患招募管理市場（2018-2030）
    • 病患招募和註冊服務
    • 患者保留
    • 其他
  • 資料管理
    • 資料管理市場（2018-2030）
  • 管理人員
    • 行政人員市場（2018-2030）
  • IRBS
    • IRB 市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第6章臨床實驗支持服務市場：贊助商的估計和趨勢分析

  • 臨床實驗支援服務市場：細分儀表板（按贊助商分類）
  • 臨床實驗支援服務市場：按發起方進行的趨勢分析
  • 依贊助商分類（2018-2030）
  • 製藥和生物製藥公司
    • 製藥和生物製藥公司市場（2018-2030 年）
  • 醫療設備公司
    • 醫療設備公司市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第7章臨床實驗支援服務市場：區域估計與趨勢分析

  • 按地區分類的市場佔有率分析（2023 年和 2030 年）
  • 市場儀表板：按地區
  • 全球市場概況：按地區
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 公司市場佔有率分析（2023 年）
  • 公司簡介
    • Charles River Laboratories International, Inc.
    • Wuxi Apptec, Inc
    • Iqvia Holdings, Inc
    • Syneos Health, Inc.
    • Eurofins Scientific
    • PPD, Inc. (Pharmaceutical Product Development)
    • Icon Plc
    • Laboratory Corporation of America Holdings (Labcorp)
    • Alcura
    • Parexel International Corporation
Product Code: GVR-4-68039-475-9

Clinical Trials Support Services Market Growth & Trends:

The global clinical trials support services market size is expected to reach USD 37.16 billion in 2030 and is projected to grow at a CAGR of 7.72% from 2025 to 2030. Increasing the number of CROs offering clinical trial support services, and huge investment in research & development by the pharmaceutical and biopharmaceutical companies are the key factors driving the market growth. The industry felt the impact of the COVID-19 pandemic. The pandemic disrupted the supply chain to a severe extent in 2020. However, it also revealed ways to grow, either through M&A or through the adoption of digital technologies in clinical research.

Clinical trials encounter some concerning statistics, such as 85% of the clinical trials fail to recruit enough participants, 80% are delayed due to recruiting challenges, and the rate of dropout of participants is increasing. However, to overcome this, a patient retention strategy that is engaging and gives clarity is required. It is critical to ensure that the informed consent materials are simple to grasp. According to a CISCRP study, 35% of trial participants who later dropped out stated that informed consent was difficult to comprehend. An average American is 7th to 8th grade educated, and it is critical to guarantee and analyze the material's readability before submitting it to the Institutional Review Board (IRB).

Adoption of virtual clinical trials across the clinical trials support services industry is one of the major factors that has boosted revenue growth post-pandemic. An increasing number of clinical research organizations are focusing on the adoption of virtual technologies to streamline their clinical research services. According to the latest Annual CRO Report by the Veeva Unified Clinical Operations Survey, CROs are making significant advancements to speed up and modernize clinical trials. Findings from Veeva Systems reflect that CROs have taken decisive action to streamline trial execution by adopting new technologies and digital strategies that replace manual processes, eradicate information siloes, and enable trial collaborations.

Clinical Trials Support Services Market Report Highlights:

  • The clinical trial site management accounted for the largest market share of 45.73% in 2024.. High cost associated with site monitoring and site recruitment is one the key factors for the largest share.
  • The phase III segment dominated the market, accounting for a revenue share of 54.43%. Phase III clinical trials are highly expensive due to the involvement of huge subjects. The failure rate in this phase is the highest as the sample size and study design require complex dosing at an optimum level.
  • Pharmaceutical & biopharmaceutical companies' segment dominated the market with the largest revenue share of 70.80% in 2024. Increasing R&D investments and the introduction of new drugs are primarily driving the segment market.
  • North America dominated the global market in 2024 with the largest share of 48.80%, as most pharmaceutical businesses in the U.S. perform most of their business in this region

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Phases
    • 1.2.2. Service
    • 1.2.3. Sponsor
  • 1.3. Regional Scope
  • 1.4. Estimates And Forecast Timeline
  • 1.5. Objectives
    • 1.5.1. Objective-1
    • 1.5.2. Objective-2
    • 1.5.3. Objective-3
  • 1.6. Research Methodology
  • 1.7. Information Procurement
    • 1.7.1. Purchased Database
    • 1.7.2. GVR's Internal Database
    • 1.7.3. Secondary Sources
    • 1.7.4. Primary Research
  • 1.8. Information Or Data Analysis
    • 1.8.1. Data Analysis Models
  • 1.9. Market Formulation & Validation
  • 1.10. Model Details
    • 1.10.1. Commodity Flow Analysis
    • 1.10.2. Parent Market Analysis
  • 1.11. List Of Secondary Sources
  • 1.12. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Support Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Trials Support Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis
    • 3.3.4. Major Deals & Strategic Alliances Analysis

Chapter 4. Clinical Trials Support Services Market: Phases Estimates & Trend Analysis

  • 4.1. Clinical Trials Support Services Market, By Phases: Segment Dashboard
  • 4.2. Clinical Trials Support Services Market, By Phases: Movement Analysis
  • 4.3. Clinical Trials Support Services Market Estimates & Forecasts, By Phases, 2018 - 2030
  • 4.4. Phase I
    • 4.4.1. Phase I Market, 2018 to 2030 (USD Million)
    • 4.4.2. Clinical Trial Site Management
      • 4.4.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
    • 4.4.3. Patient Recruitment Management
      • 4.4.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
    • 4.4.4. Data Management
      • 4.4.4.1. Data Management Market, 2018 to 2030 (USD Million)
    • 4.4.5. Administrative Staff
      • 4.4.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
    • 4.4.6. IRB
      • 4.4.6.1. IRB Market, 2018 to 2030 (USD Million)
    • 4.4.7. Others
      • 4.4.7.1. Others Market, 2018 to 2030 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market, 2018 to 2030 (USD Million)
    • 4.5.2. Clinical Trial Site Management
      • 4.5.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
    • 4.5.3. Patient Recruitment Management
      • 4.5.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
    • 4.5.4. Data Management
      • 4.5.4.1. Data Management Market, 2018 to 2030 (USD Million)
    • 4.5.5. Administrative Staff
      • 4.5.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
    • 4.5.6. IRB
      • 4.5.6.1. IRB Market, 2018 to 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others Market, 2018 to 2030 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market, 2018 to 2030 (USD Million)
    • 4.6.2. Clinical Trial Site Management
      • 4.6.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
    • 4.6.3. Patient Recruitment Management
      • 4.6.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
    • 4.6.4. Data Management
      • 4.6.4.1. Data Management Market, 2018 to 2030 (USD Million)
    • 4.6.5. Administrative Staff
      • 4.6.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
    • 4.6.6. IRB
      • 4.6.6.1. IRB Market, 2018 to 2030 (USD Million)
    • 4.6.7. Others
      • 4.6.7.1. Others Market, 2018 to 2030 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market, 2018 to 2030 (USD Million)
    • 4.7.2. Clinical Trial Site Management
      • 4.7.2.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
    • 4.7.3. Patient Recruitment Management
      • 4.7.3.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
    • 4.7.4. Data Management
      • 4.7.4.1. Data Management Market, 2018 to 2030 (USD Million)
    • 4.7.5. Administrative Staff
      • 4.7.5.1. Administrative Staff Market, 2018 to 2030 (USD Million)
    • 4.7.6. IRB
      • 4.7.6.1. IRB Market, 2018 to 2030 (USD Million)
    • 4.7.7. Others
      • 4.7.7.1. Others Market, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Support Services Market: Service Estimates & Trend Analysis

  • 5.1. Clinical Trials Support Services Market, By Service: Segment Dashboard
  • 5.2. Clinical Trials Support Services Market, By Service: Movement Analysis
  • 5.3. Clinical Trials Support Services Market Estimates & Forecasts, By Service, 2018 - 2030
  • 5.4. Clinical Trial Site Management
    • 5.4.1. Clinical Trial Site Management Market, 2018 to 2030 (USD Million)
  • 5.5. Patient Recruitment Management
    • 5.5.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
    • 5.5.2. Patient recruitment & Registry Services
      • 5.5.2.1. Patient Recruitment Management Market, 2018 to 2030 (USD Million)
    • 5.5.3. Patient retention
      • 5.5.3.1. Patient Retention Market, 2018 to 2030 (USD Million)
    • 5.5.4. Others
      • 5.5.4.1. Others Market, 2018 to 2030 (USD Million)
  • 5.6. Data Management
    • 5.6.1. Data Management Market, 2018 to 2030 (USD Million)
  • 5.7. Administrative Staff
    • 5.7.1. Administrative Staff Market, 2018 to 2030 (USD Million)
  • 5.8. IRB
    • 5.8.1. IRB Market, 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Support Services Market: Sponsor Estimates & Trend Analysis

  • 6.1. Clinical Trials Support Services Market, By Sponsor: Segment Dashboard
  • 6.2. Clinical Trials Support Services Market, By Sponsor: Movement Analysis
  • 6.3. Clinical Trials Support Services Market Estimates & Forecasts, By Sponsor, 2018 - 2030
  • 6.4. Pharmaceutical & biopharmaceutical companies
    • 6.4.1. Pharmaceutical & biopharmaceutical companies Market, 2018 to 2030 (USD Million)
  • 6.5. Medical device companies
    • 6.5.1. Medical device companies Market, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trials Support Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2018 - 2030
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030
    • 7.6.7. Australia
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
    • 7.7.4. Colombia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share Analysis, 2023
  • 8.3. Company Profiles
    • 8.3.1. Charles River Laboratories International, Inc.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Wuxi Apptec, Inc
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Iqvia Holdings, Inc
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Syneos Health, Inc.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Eurofins Scientific
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. PPD, Inc. (Pharmaceutical Product Development)
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Icon Plc
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Laboratory Corporation of America Holdings (Labcorp)
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Alcura
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Parexel International Corporation
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trials Support Services, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Clinical Trials Support Services, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 11 U.S Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 12 U.S Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 13 U.S Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 14 Canada Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 15 Canada Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 16 Canada Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 17 Mexico Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 18 Mexico Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 19 Mexico Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 20 Europe Clinical Trials Support Services, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 22 Europe Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 23 Europe Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 24 UK Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 25 UK Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 26 UK Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 27 Germany Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 28 Germany Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 29 Germany Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 30 France Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 31 France Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 32 France Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 33 Italy Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 34 Italy Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 35 Italy Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 36 Spain Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 37 Spain Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 38 Spain Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 39 Sweden Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 40 Sweden Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 41 Sweden Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 42 Denmark Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 43 Denmark Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 44 Denmark Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 45 Norway Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 46 Norway Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 47 Norway Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Clinical Trials Support Services, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 52 Japan Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 53 Japan Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 54 Japan Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 55 China Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 56 China Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 57 China Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 58 India Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 59 India Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 60 India Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 61 Thailand Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 62 Thailand Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 63 Thailand Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 64 South Korea Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 65 South Korea Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 66 South Korea Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 67 Australia Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 68 Australia Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 69 Australia Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 70 Latin America Clinical Trials Support Services, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 72 Latin America Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 73 Latin America Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 74 Brazil Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 75 Brazil Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 76 Brazil Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 77 Argentina Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 78 Argentina Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 79 Argentina Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 80 Colombia Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 81 Colombia Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 82 Colombia Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Clinical Trials Support Services, by Country, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 85 Middle East & Africa Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 86 Middle East & Africa Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 87 South Africa Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 88 South Africa Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 89 South Africa Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 93 UAE Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 94 UAE Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 95 UAE Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Clinical Trials Support Services, by Phases, 2018 - 2030 (USD Million)
  • Table 97 Kuwait Clinical Trials Support Services, by Service, 2018 - 2030 (USD Million)
  • Table 98 Kuwait Clinical Trials Support Services, by Sponsor, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Clinical Trials Support Services Market revenue, 2018-2030 (USD Million)
  • Fig. 10 Clinical Trials Support Services Market snapshot
  • Fig. 11 Clinical Trials Support Services Market driver impact
  • Fig. 12 Clinical Trials Support Services Market restraint impact
  • Fig. 13 Clinical Trials Support Services sector key takeaways (USD Million)
  • Fig. 14 Clinical Trials Support Services Market: Phases movement analysis
  • Fig. 15 Phase I market, 2018 - 2030 (USD Million)
  • Fig. 16 Phase II market, 2018 - 2030 (USD Million)
  • Fig. 17 Phase III market, 2018 - 2030 (USD Million)
  • Fig. 18 Phase IV market, 2018 - 2030 (USD Million)
  • Fig. 19 Clinical Trials Support Services Market Service key takeaways (USD Million)
  • Fig. 20 Clinical Trials Support Services Market: service movement analysis
  • Fig. 21 Clinical Trial Site Management market, 2018 - 2030 (USD Million)
  • Fig. 22 Patient Recruitment Management market, 2018 - 2030 (USD Million)
  • Fig. 23 Patient recruitment & Registry Services market, 2018 - 2030 (USD Million)
  • Fig. 24 Patient retention market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Data Management market, 2018 - 2030 (USD Million)
  • Fig. 27 Administrative Staff market, 2018 - 2030 (USD Million)
  • Fig. 28 IRB market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical Trials Support Services Market Sponsor key takeaways (USD Million)
  • Fig. 31 Clinical Trials Support Services Market: sponsor movement analysis
  • Fig. 32 Pharmaceutical & biopharmaceutical companies' market, 2018 - 2030 (USD Million)
  • Fig. 33 Medical device companies' market, 2018 - 2030 (USD Million)
  • Fig. 34 Others market, 2018 - 2030 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Regional outlook, 2023 & 2030
  • Fig. 37 North America Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 42 UK Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 44 France Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain companion animal Health market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 49 Norway Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 52 China Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 53 India Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 60 Colombia Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East & Africa Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 64 UAE Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait Clinical Trials Support Services Market, 2018 - 2030 (USD Million)
  • Fig. 66 Market participant categorization